From: 2021 - State of our JCMR
Bandettini et al. | A comparison of cine CMR imaging at 0.55 T and 1.5 T. [15] |
Champ-Rigot et al. | Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance. [36] |
Jacobs et al. | Direct measurement of atrioventricular valve regurgitant jets using 4D flow cardiovascular magnetic resonance is accurate and reliable for children with congenital heart disease: a retrospective cohort study. [37] |
Kranzusch et al. | Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: Normal behavior and validation in patients with amyloidosis. [38] |
Lindemann et al. | Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms [39] |
Liu et al. | Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance. [31] |
Martini et al. | Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance. [40] |
Olivieri et al. | Normal right and left ventricular volumes prospectively obtained from cardiovascular magnetic resonance in awake, healthy, 0–12 year old children. [41] |
Qiao et al. | Quantitative evaluation of carotid atherosclerotic vulnerable plaques using in vivo T1 mapping cardiovascular magnetic resonaonce: validation by histology. [42] |
Reddy et al. | Invasive cardiovascular magnetic resonance (iCMR) for diagnostic right and left heart catheterization using an MR-conditional guidewire and passive visualization in congenital heart disease. [16] |